title: Recombinant human erythropoietin for the treatment of anemia in chronic myelogenous leukemia.
authors.forename: K L
authors.initials: KL
authors.lastname: Bourantas
authors.forename: S
authors.initials: S
authors.lastname: Tsiara
authors.forename: A
authors.initials: A
authors.lastname: Makis
authors.forename: A
authors.initials: A
authors.lastname: Chaidos
authors.forename: L
authors.initials: L
authors.lastname: Christou
authors.forename: P
authors.initials: P
authors.lastname: Konstantinidou
authors.forename: G
authors.initials: G
authors.lastname: Kolios
authors.forename: K
authors.initials: K
authors.lastname: Seferiadis
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D004921:Erythropoietin / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin